Safety profile of almotriptan, a new antimigraine agent. Effects on central nervous system, renal function and respiratory dynamics.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D004285:Dogs; D004347:Drug Interactions; D006168:Guinea Pigs; D007211:Indoles / Q000009:adverse effects*; D007668:Kidney / Q000187:drug effects; D007677:Kidney Function Tests; D008297:Male; D051379:Mice; D008881:Migraine Disorders / Q000188:drug therapy*; D051381:Rats; D015656:Respiratory Mechanics / Q000187:drug effects; D017366:Serotonin Receptor Agonists / Q000009:adverse effects*; D018170:Sumatriptan / Q000009:adverse effects; D014363:Tryptamines